Biotech Values

[DewDiligence]

MYL’s acquisition of Agila (#msg-85095031) may be in doubt:

http://online.wsj.com/article/SB10001424127887324139404579016782936626884.html

In July, the Indian government froze U.S. drug maker Mylan Inc.'s proposed $1.6 billion acquisition of Agila Specialties Pvt. Ltd., an Indian manufacturer of injectable cancer drugs. The government was concerned that these drugs would be exported to more lucrative markets abroad, reducing the domestic supply.

India's Prime Minister Manmohan Singh on Friday asked the Department of Industrial Policy and Promotion to suggest possible changes to investment regulations, a senior government official told The Wall Street Journal.